Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanotechnology and Life Sciences: Science and Business Perspectives

Abstract:
Dr Mostafa Analoui, PHD, Senior Director at Pfizer Global Research and Development is confirmed to speak on critical needs in clinical diagnostics and key challenges in drug discovery and development at Biopharmaceutical Nanotechnology http://www.iqpc.com/uk/nanotech/nnow in London, UK on 31st March - 1st April 2008.

Nanotechnology and Life Sciences: Science and Business Perspectives

Connecticut, USA and London, UK | Posted on January 17th, 2008

Research and Development in Life Sciences are greatly impacted by recent advances in conventional and emerging technologies, especially in understanding of disease, drug discovery, and novel diagnostics. These technological contributions have led to innovation and introduction of a number of therapeutic solutions with notable improvement in public health. Nanobiotechnology, a basket of wide ranging technologies, is being positioned as one of critical class of technologies, with broad reaching impacts in Life Science R&D, including drug discovery, formulation, delivery, clinical assessment and monitoring.

Nanobiotechnology's impact within drug discovery and development is manifesting itself in two ways, with different time horizons. The immediate and short term impact is being materialized through innovative formulation and delivery of compounds in different stages of development, including the ones already in the market. In the longer term horizon, there is a promise of new class of drugs designed around nanobiotechnology approach from ground up. There are early indicators of such potential success stories worth allocating resources and attention.

Dr Mostafa Analoui's presentation at the Biopharmaceutical Nanotechnology conference in London, UK will discuss some of the areas that nanobiotechnology could play through enhancement in current paradigm, as well as new directions in drug development, using examples of current utility of nanotechnology, as well as ongoing research areas. Dr Analoui will also provide delegates with a snapshot of global business and investment environment around nanobiotechnology, including current and projected level of private and government investments, trends in IP ownership, as well as fundamental questions around assessment of investment strategies and risks.

As well as being a Senior Director at Pfizer Global Research and Development in Connecticut Dr Analoui is also adjunct Professor of Radiology and Oral Pathology, Medicine at Indiana University Schools of Medicine and Dentistry. Dr Analoui is actively involved in management and scientific/business development of novel biotechnologies and methodologies, global strategies and education. Dr Analoui was previously the Director of Oral and Maxillofacial Imaging Research at Indiana University, and Associate professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc.

In addition to industry leadership in biomedical filed, he lectures nationally and internationally. He has also served on various scientific and business advisory committees and boards. Dr. Analoui has authored over 130 publications, including journal articles, book chapters, and technical reports.

####

About Biopharmaceutical Nanotechnology 2008
The use of Nanotechnology in the discovery and development of biopharmaceuticals is a major breakthrough, with the potential to revolutionise and enhance your ability to develop new and innovative products.

Biopharmaceutical Nanotechnology is the first industry-led event in Europe focussing on drug discovery, drug delivery and particular therapeutic areas. Join global experts for a practical, commercially applicable perspective on how to:

Stay competitive by applying the experience of key industry players who have used nanotechnology in the administration of drugs

Discover how nanotechnology combines drugs and devices to increase your product efficiency

Learn the best ways to implement drug discovery techniques into your business processes

Discuss how to employ latest therapeutic developments into your product pipeline

For further information, visit http://www.iqpc.com/uk/nanotech/nnow

For more information, please click here

Copyright © Biopharmaceutical Nanotechnology 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

HP Supercomputer at NREL Garners Top Honor October 19th, 2014

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

Ucore's McKenzie to Deliver Presentation to Rare Earths Conference in Singapore as Highlight of Fall 2014 Marketplace Schedule October 19th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

Announcements

HP Supercomputer at NREL Garners Top Honor October 19th, 2014

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

Ucore's McKenzie to Deliver Presentation to Rare Earths Conference in Singapore as Highlight of Fall 2014 Marketplace Schedule October 19th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

Events/Classes

Ucore's McKenzie to Deliver Presentation to Rare Earths Conference in Singapore as Highlight of Fall 2014 Marketplace Schedule October 19th, 2014

Aspen Aerogels, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 October 17th, 2014

New VDMA Association "Electronics, Micro and Nano Technologies" founded: Inaugural Meeting in Frankfurt/Main, Germany October 15th, 2014

Nanotronics Imaging Releases nSPECŪ 3D, Powerful Microscope That Captures 3D Images at Nanoscale, in Lightning Speed: Company Unveils Design at American Chemical Society 2014 International Elastomer Conference October 14th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE